EUVIMEDEUVIMED entdecken
Systematische Übersicht

Systematic Review and Quantitative Comparative Analysis of Antimicrobial Efficacy, Target Binding, and Resistance Profiles of iChip-Derived Compounds, Including Teixobactin and Its Analogs

Microbial Bioactives · 01.05.2026 · 9 (1) · 1-17

DOI: 10.25163/microbbioacts.9110743 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Microbial Bioactives, online erschienen am 01.05.2026.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The accelerating crisis of antimicrobial resistance (AMR) has, in recent years, forced a reconsideration of how antibiotics are discovered, optimized, and ultimately deployed. Within this shifting landscape, iChip technology—by enabling access to previously unculturable microorganisms—has emerged as a quietly transformative tool. This systematic review and quantitative comparative synthesis attempts to bring some coherence to an otherwise fragmented body of literature surrounding iChip-derived antibiotics, particularly teixobactin and its analogues. Sixteen studies were systematically identified and analyzed under the PRISMA 2020 framework, integrating antimicrobial activity (MIC), target-binding interactions, resistance dynamics, and translational outcomes. The findings, perhaps unsurprisingly yet still striking, confirm that teixobactin maintains exceptional potency against Gram-positive pathogens, often at sub-microgram levels. And yet, the story does not remain so straightforward. Synthetic analogues—while more accessible—frequently display reduced efficacy, suggesting a delicate dependence on structural precision. More intriguingly, the relationship between binding affinity and antimicrobial activity appears inconsistent, hinting that efficacy extends beyond simple target engagement. Resistance, long considered negligible, emerges instead as a low-probability but tangible outcome, often mediated through tolerance pathways rather than direct mutation. Taken together, these results suggest that iChip-derived antibiotics represent not a definitive solution, but rather an evolving paradigm—one defined as much by its promise as by its complexity.

Zitieren

APA

(2026). Systematic Review and Quantitative Comparative Analysis of Antimicrobial Efficacy, Target Binding, and Resistance Profiles of iChip-Derived Compounds, Including Teixobactin and Its Analogs. Microbial Bioactives, 9(1), 1-17. https://doi.org/10.25163/microbbioacts.9110743

Vancouver

Systematic Review and Quantitative Comparative Analysis of Antimicrobial Efficacy, Target Binding, and Resistance Profiles of iChip-Derived Compounds, Including Teixobactin and Its Analogs. Microbial Bioactives. 2026;9(1):1-17. doi:10.25163/microbbioacts.9110743

BibTeX
@article{euvimed2026,
  title = {Systematic Review and Quantitative Comparative Analysis of Antimicrobial Efficacy, Target Binding, and Resistance Profiles of iChip-Derived Compounds, Including Teixobactin and Its Analogs},
  journal = {Microbial Bioactives},
  year = {2026},
  volume = {9},
  number = {1},
  pages = {1--17},
  doi = {10.25163/microbbioacts.9110743}
}
Kostenlos starten →